Viva Biotech Holdings (VB0) — Net Asset Quality Index
Viva Biotech Holdings (VB0) has a Net Asset Quality Index of 56.8% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €6.88 Billion minus total liabilities of €2.98 Billion yields net assets of €3.91 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check VB0 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Viva Biotech Holdings Net Asset Quality Index Over Time (2016–2024)
This chart shows how Viva Biotech Holdings's Net Asset Quality Index has evolved across 9 annual periods from 2016 to 2024. As of June 2025, the index stands at 56.8%, representing net assets of €3.91 Billion against total assets of €6.88 Billion EUR. See how liquid is Viva Biotech Holdings's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Viva Biotech Holdings (2016–2024)
The table below presents the year-by-year Net Asset Quality Index for Viva Biotech Holdings from 2016 to 2024, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of Viva Biotech Holdings.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 54.1% | €3.82 Billion | €7.05 Billion | €3.23 Billion | ▲ +4.6 pp |
| 2023 | 49.5% | €3.69 Billion | €7.45 Billion | €3.76 Billion | ▲ +4.0 pp |
| 2022 | 45.5% | €3.60 Billion | €7.92 Billion | €4.32 Billion | ▼ -3.1 pp |
| 2021 | 48.6% | €3.91 Billion | €8.04 Billion | €4.13 Billion | ▲ +2.6 pp |
| 2020 | 46.1% | €3.76 Billion | €8.15 Billion | €4.40 Billion | ▼ -47.5 pp |
| 2019 | 93.6% | €1.78 Billion | €1.90 Billion | €121.39 Million | ▲ +46.1 pp |
| 2018 | 47.5% | €251.44 Million | €529.34 Million | €277.90 Million | ▼ -28.0 pp |
| 2017 | 75.5% | €152.76 Million | €202.40 Million | €49.64 Million | ▲ +0.3 pp |
| 2016 | 75.1% | €76.50 Million | €101.82 Million | €25.32 Million | — |